<< back to Press

Fashion Targets Breast Cancer

December 17, 2017 - December 17, 2017   



FashionTargets Breast Cancer® is licensed by the Council of Fashion Designers ofAmerica / CFDA Foundation, Inc.,

USA
  





FASHION TARGETS BREAST CANCER ANNOUNCE ONE-OFF GIG ”˜FTBC ON THE QT’ WITH A LITTLE HELP FROM CELEBRITY FRIENDS PEARL LOWE, SOPHIE ELLIS-BEXTOR, THE CHEEK & BEN GRIMES 



Fashion Targets Breast Cancer today announces the launch of FTBC on the QT; an exclusive event featuring Pearl Lowe, Sophie Ellis-Bextor, and the Cheek, alongside a whole host of special guests from London’s fashion set at London’s legendary venue The Proud Galleries on November 11th.Hosted by the first lady of rock-chick chic, Pearl Lowe, the star-studded event will see the likes ofSophie Ellis-Bextor and The Cheek performing live in front of a small audience followed by DJ sets from Ben Grimes and Razorlight band members David ”˜Skully’ Sullivan-Kaplan and Carl Dalemo.  The audience will have a chance to get up close and personal with pop princess Sophie Ellis-Bextor, who will treat music lovers to a sneak preview of tracks from her forthcoming album as well as some of her biggest hits.  Quirky new pop band The Cheek will shake things up with a performance of their hotly anticipated debut single “Hung Up”.  And as if that wasn’t enough, after the live performances, model of the moment Ben Grimes will be hitting the decks, closely followed by David ”˜Skully’ Sullivan-Kaplan and Carl Dalemo of indie outfit Razorlight, who will ensure the party keeps rocking all night long. Guests will include some of Fashion Targets’ most loyal supporters from the fashion and music industries, including fashion forward celebrities and the cream of the crop from the London style scene.  A limited number of tickets for this event will be released on general sale on the 2nd November 2009. To be in with a chance of getting one of the hottest tickets this November visit www.ftbcontheqt.com.   Tickets are priced at £30 each and all transactions will be made via ticket master who are proud sponsors of FTBC on the QT. FTBC on the QT are also delighted to announce Grazia as the ”˜official media partner’ of this intimate event.  Natalie Legg, from Fashion Targets Breast Cancer comments:  FTBC on the QT is our way of saying a huge thank you to all our supporters old and new for remaining loyal over the years and helping us to continue to fight breast cancer.  We are really looking forward to sharing this special evening with everyone and bringing the  fashion and music industry together in support of Fashion Targets Breast Cancer.  



For more information please contact Dee Graves or Megan MacLeod at SLAM PR on
This email address is being protected from spambots. You need JavaScript enabled to view it.
020 7067 2281 / This email address is being protected from spambots. You need JavaScript enabled to view it.
020 7067 0331





NOTES TO EDITORS
ABOUT FASHION TARGETS BREAST CANCER

Since the FTBC campaign was launched in the UK in 1996, it has raised over £10.5 million for Breakthrough Breast Cancer’s ground-breaking research, campaigning and education work.  This work has included opening and funding research at the UK’s first dedicated breast cancer research centre which now houses over 120 world-class scientists.  Building on the success of the centre, Breakthrough recently set up three new research units across the UK.



FASHION TARGETS BREAST CANCER ·         Fashion Targets Breast Cancer is a worldwide initiative inspired by Ralph Lauren in the USA in 1994 as the fashion industry’s response to the devastating impact of breast cancer·         Find out more about the campaign at www.fashiontargetsbreastcancer.org.uk



ABOUT BREAST CANCER  

Nearly 46,000 women and around 300 men are diagnosed with breast cancer each year in the UK·         Breast cancer is the most commonly diagnosed cancer in the UK and 1 in 9 women in the UK will develop breast cancer at some point in their lifetime ·         More women than ever in the UK are surviving breast cancer thanks to better awareness, better screening and better treatments  




<< back to Press